Orbital Intra-osseous Infantile Haemangioma in an 8-month-old Infant: A Case Report

Cerise Jamin; Annabel Maruani; Gregoire Boulouis; Lola Beele; Aline Joly

doi:10.2340/actadv.v105.42507

Authors

Cerise Jamin University Hospital Center (CHRU) of Tours, Department of Maxillofacial surgery, Tours, France
Annabel Maruani Reference center for genodermatoses and rare skin diseases (MAGEC-Tours), Tours, France; University Hospital Center (CHRU) of Tours, Department of Dermatology, Unit of Pediatric dermatology, Tours, France
Gregoire Boulouis Reference center for genodermatoses and rare skin diseases (MAGEC-Tours), Tours, France; University Hospital Center (CHRU) of Tours, Department of Interventional Neuroradiology, Tours, France
Lola Beele University Hospital Center (CHRU) of Tours, Department of Pathology, Tours, France
Aline Joly University Hospital Center (CHRU) of Tours, Department of Maxillofacial surgery, Tours, France; Reference center for genodermatoses and rare skin diseases (MAGEC-Tours), Tours, France 3University Hospital Center (CHRU) of Tours, Department of Dermatology, Unit of Pediatric dermatology, Tours, France

DOI:

https://doi.org/10.2340/actadv.v105.42507

Keywords:

infantile hemangioma, orbital, intra-osseous

Downloads

Download data is not yet available.

References

Hemangioma Investigator Group, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007; 150: 291 294.

https://doi.org/10.1016/j.jpeds.2006.12.003 DOI: https://doi.org/10.1016/j.jpeds.2006.12.003

Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015; 372: 735-746.

https://doi.org/10.1056/NEJMoa1404710 DOI: https://doi.org/10.1056/NEJMoa1404710

Chen T, Gudipudi R, Nguyen SA, Carroll W, Clemmens C. Should propranolol remain the gold standard for treatment of infantile hemangioma? A systematic review and meta-analysis of propranolol versus atenolol Ann Otol Rhinol Laryngol 2023; 132: 332-340.

https://doi.org/10.1177/00034894221089758 DOI: https://doi.org/10.1177/00034894221089758

Robert J, Tavernier E, Boccara O, Mashiah J, Mazereeuw-Hautier J, Maruani A. Modalities of use of oral propranolol in proliferative infantile haemangiomas: an international survey among practitioners. Br J Dermatol 2020; 183: 573-575.

https://doi.org/10.1111/bjd.19047 DOI: https://doi.org/10.1111/bjd.19047

Iacobas I, Phung TL, Adams DM, Trenor 3rd CC, Blei F, Fishman DS, et al. Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring. J Pediatr 2018; 203: 294-300.e2.

https://doi.org/10.1016/j.jpeds.2018.08.012 DOI: https://doi.org/10.1016/j.jpeds.2018.08.012

Tortorelli I, Bellan E, Chiusole B, Murtas F, Ruggieri P, Pala E, et al. Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment. Crit Rev Oncol Hematol 2024; 195: 104268.

https://doi.org/10.1016/j.critrevonc.2024.104268 DOI: https://doi.org/10.1016/j.critrevonc.2024.104268

Madge SN, Simon S, Abidin Z, Ghabrial R, Davis G, McNab A, et al. Primary orbital intraosseous hemangioma. Ophthalmic Plast Reconstr Surg 2009; 25: 37 41.

https://doi.org/10.1097/IOP.0b013e318192a27e DOI: https://doi.org/10.1097/IOP.0b013e318192a27e

Gupta D, Singh I, Goyal K, Sobti P. Infantile intraosseous maxillary hemangioma. Indian Pediatr 2016; 53: 1103 1104.

https://doi.org/10.1007/s13312-016-0918-9 DOI: https://doi.org/10.1007/s13312-016-0918-9